Fig. 5
From: The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009–2021
Distribution of clinical trials by drug mechanism in chemical polypills
Numbers beside each column of the chart represent the actual number of trials. Abbreviations: DHP, dihydropyridine; SGLT2, sodium-dependent glucose transporters 2; NPC1L1, Niemann-Pick C1 Like1; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; DDP-4, dipeptidyl peptidase-4; ARNI, angiotensin receptor-neprilysin inhibitor; GLP-1 RA, glucagon-like peptide-1 receptor agonists